Foros de Conocimiento
medtronic PRODUCTOS
boston_scientific PRODUCTOS
TERUMO PRODUCTOS
Biotronik PRODUCTOS
Sirtex PRODUCTOS
Striker Neurovascular PRODUCTOS
BIOSENSORS PRODUCTOS

ABSTRACT


15 marzo 2022

Transcatheter Tricuspid Valve Replacement With the EVOQUE System: 1-Year Outcomes of a Multicenter, First-in-Human Experience

John G. Webb, Anthony (Ming-yu) Chuang, David Meier, Ralph Stephan von Bardeleben, Susheel K. Kodali, Robert L. Smith, Jörg Hausleiter, Geraldine Ong, Robert Boone, Tobias Ruf, Isaac George, Molly Szerlip, Michael Näbauer, Faeez M. Ali, Robert Moss, Felix Kreidel, Vinayak Bapat, Katharina Schnitzler, Jian Ye, Mirjam Wild, Mariama Akodad, Djeven P. Deva, Andrew G. Chatfield, Michael J. Mack, Paul A. Grayburn, Mark D. Peterson, Raj Makkar, Martin B. Leon, Rebecca T. Hahn, and Neil P. Fam

Objectives The aim of this study was to report the midterm outcomes at 1 year in the expanded first-in-human experience with the transfemoral EVOQUE system (Edwards Lifesciences) for tricuspid regurgitation (TR).

15 marzo 2022

Transfemoral Tricuspid Valve Replacement in Patients With Tricuspid Regurgitation: TRISCEND Study 30-Day Results

Susheel Kodali, Rebecca T. Hahn, Isaac George, Charles J. Davidson, Akhil Narang, Firas Zahr, Scott Chadderdon, Robert Smith, Paul A. Grayburn, William W. O’Neill, Dee Dee Wang, Howard Herrmann, Frank Silvestry, Sammy Elmariah, Ignacio Inglessis, Jonathan Passeri, D. Scott Lim, Michael Salerno, Moody Makar, Michael J. Mack, Martin B. Leon, Raj Makkar, and on behalf of the TRISCEND Investigators

Objectives The TRISCEND study (Edwards EVOQUE Tricuspid Valve Replacement: Investigation of Safety and Clinical Efficacy after Replacement of Tricuspid Valve with Transcatheter Device) is evaluating the safety and performance of transfemoral transcatheter tricuspid valve replacement in patients with clinically significant tricuspid regurgitation (TR) and elevated surgical risk.

15 marzo 2022

FFR- Versus Angiography-Guided Revascularization for Nonculprit Stenosis in STEMI and Multivessel Disease: A Network Meta-Analysis

Ayman Elbadawi, Alexander T. Dang, Mohamed Hamed, Mennaallah Eid, Meghana Prakash Hiriyur Prakash, Mohammed Saleh, Mohamed Gad, Mamas A. Mamas, Faisal Rahman, and Islam Y. Elgendy

Objectives The aim of this study was to examine the efficacy and safety of fractional flow reserve (FFR)–guided versus angiography-guided approaches for nonculprit stenosis among patients with acute ST-segment elevation myocardial infarction (STEMI) and multivessel disease.

15 marzo 2022

Sex Differences in Management and Outcomes of Acute Myocardial Infarction Patients Presenting With Cardiogenic Shock

Islam Y. Elgendy, Zachary K. Wegermann, Shuang Li, Dhruv Mahtta, Maria Grau-Sepulveda, Nathaniel R. Smilowitz, Martha Gulati, Kirk N. Garratt, Tracy Y. Wang, and Hani Jneid

Objectives The aim of this study was to examine the sex differences in the risk profile, management, and outcomes among patients presenting with acute myocardial infarction cardiogenic shock (AMI-CS).

15 marzo 2022

1-Year Outcomes of Fluoropolymer-Based Drug-Eluting Stent in Femoropopliteal Practice: Predictors of Restenosis and Aneurysmal Degeneration

Osamu Iida, Mitsuyoshi Takahara, Yoshimitsu Soga, Terutoshi Yamaoka, Masahiko Fujihara, Daizo Kawasaki, Shigeo Ichihashi, Amane Kozuki, Shinsuke Nanto, Yasushi Sakata, Toshiaki Mano, and on behalf of the CAPSICUM Investigators

Objectives This study aimed to investigate the 1-year risk of restenosis and aneurysmal degeneration and explore the associated factors after femoropopliteal implantation of fluoropolymer-based drug-eluting stents (FP-DESs) for symptomatic atherosclerotic peripheral artery disease in real-world practice.

15 marzo 2022

Same-Day Discharge Post–Transcatheter Aortic Valve Replacement During the COVID-19 Pandemic: The Multicenter PROTECT TAVR Study

Madeleine Barker, Janarthanan Sathananthan, Emily Perdoncin, Chandan Devireddy, Patricia Keegan, Kendra Grubb, Andrei M. Pop, Jeremiah P. Depta, Devesh Rai, Farhad Abtahian, Mark S. Spence, Jonathan Mailey, Douglas F. Muir, Mark J. Russo, Jennifer Pineda-Salazar, Alexis Okoh, Meghan Smith, Thom G. Dahle, Masud Rana, Mesfer Alfadhel, David Meier, Andrew Chatfield, Mariama Akodad, Anthony Chuang, Rohit Samuel, Thomas Nestelberger, Cameron McAlister, Sandra Lauck, John G. Webb, and David A. Wood

Objectives The aim of this study was to determine the safety and efficacy of same-day discharge (SDD) after transcatheter aortic valve replacement (TAVR) during the COVID-19 pandemic.

15 marzo 2022

Feasibility and Safety of Same-Day Discharge Following Transfemoral Transcatheter Aortic Valve Replacement

Amar Krishnaswamy, Toshiaki Isogai, Ankit Agrawal, Shashank Shekhar, Rishi Puri, Grant W. Reed, James J. Yun, Shinya Unai, Daniel J.P. Burns, Patrick R. Vargo, and Samir R. Kapadia

Objectives This study evaluated the feasibility and safety of same-day discharge (SDD) following transfemoral transcatheter aortic valve replacement (TF-TAVR) compared with next-day discharge (NDD)

15 marzo 2022

Trends in Clinical Presentation, Management, and Outcomes of STEMI in Patients With COVID-19

Santiago Garcia, Payam Dehghani, Larissa Stanberry, Cindy Grines, Rajan A.G. Patel, Keshav R. Nayak, Avneet Singh, Wah Wah Htun, Ameer Kabour, Nima Ghasemzadeh, Cristina Sanina, Joseph Aragon, M. Chadi Alraies, Catherine Benziger, Brynn Okeson, Ross Garberich, Frederick G. Welt, Laura Davidson, Abdul Moiz Hafiz, Deepak Acharya, Jay Stone, Aditya Mehra, Shy Amlani, Ehtisham Mahmud, Jay Giri, Mehmet Yildiz, and Timothy D. Henry

Background We previously reported high in-hospital mortality for ST-segment elevation myocardial infarction (STEMI) patients with COVID-19 treated in the early phase of the pandemic.

15 marzo 2022

Safety of Provocative Testing With Intracoronary Acetylcholine and Implications for Standard Protocols

Tatsunori Takahashi, Bruce A. Samuels, Weijia Li, Manish A. Parikh, Janet Wei, Jeffery W. Moses, William F. Fearon, Timothy D. Henry, Jennifer A. Tremmel, Yuhei Kobayashi, and on behalf of the Microvascular Network

Background Heterogeneity in diagnostic criteria and provocation protocols has posed challenges in understanding the safety of coronary provocation testing with intracoronary acetylcholine (ACh) for the contemporary diagnosis of epicardial and microvascular spasm.

01 junio 2022

False Lumen Flow Assessment by Magnetic Resonance Imaging and Long-Term Outcomes in Uncomplicated Aortic Dissection

Arturo Evangelista, Victor Pineda, Andrea Guala, Bart Bijnens, Hug Cuellar, Paula Rudenick, Augusto Sao-Aviles, Aroa Ruiz, Gisela Teixido-Tura, Rafael Rodriguez-Lecoq, Sergi Bellmunt, Ignacio Ferreira, and Jose Rodríguez-Palomares

Background Despite the absence of clinical complications after an acute aortic dissection (AD) with persistent patent false lumen (FL), a high risk for clinical events may persist.

15 mayo 2022

Cardiovascular Outcomes in Aortopathy: GenTAC Registry of Genetically Triggered Aortic Aneurysms and Related Conditions

Kathryn W. Holmes, Sheila Markwardt, Kim A. Eagle, Richard B. Devereux, Jonathan W. Weinsaft, Federico M. Asch, Scott A. LeMaire, Cheryl L. Maslen, Howard K. Song, Dianna M. Milewicz, Siddharth K. Prakash, Dongchuan Guo, Shaine A. Morris, Reed E. Pyeritz, Rita C. Milewski, William J. Ravekes, H.C. Dietz, Ralph V. Shohet, Michael Silberbach, Mary J. Roman, and on behalf of the GenTAC Investigators

Background The GenTAC (Genetically Triggered Thoracic Aortic Aneurysm and Cardiovascular Conditions) Registry enrolled patients with genetic aortopathies between 2007 and 2016.

Utilizamos cookies propias para el correcto funcionamiento del sitio web y mejorar nuestros servicios. Pulse el botón Aceptar todas para aceptar su uso. Puede cambiar la configuración u obtener más información en nuestra Política de cookies o pulsando Modificar configuración.